D. E. Shaw & Co, L.P. - Jul 18, 2025 SCHEDULE 13G/A Report for Sarepta Therapeutics, Inc. Common Stock, $0.0001 par value per share (SRPT)

Filing Manager: D. E. SHAW & CO, L.P.
Reporting Manager: D. E. Shaw & Co., L.P.
Security: Sarepta Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: SRPT
Shares outstanding: 99.2M shares
Disclosed Ownership: 5.06M shares
Ownership: 5.1%
Form type: SCHEDULE 13G/A
Date filed: 7/25/2025, 08:14 PM
Date of event: Jul 18, 2025
Next filing: Nov 14, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
D. E. Shaw & Co., L.P.	5.1%	5.06M	0	5M	/s/ Daniel R. Marcus	Daniel R. Marcus / Chief Compliance Officer
David E. Shaw	5.1%	5.06M	0	5M	/s/ Daniel R. Marcus	Daniel R. Marcus / Attorney-in-Fact for David E. Shaw